The G-Rex Grant Program is HERE!!
The G-Rex® Grant Program is a $20 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady, that is designed to propel the advancement of cell and gene therapies (CGT).
Download the Program Outline PDF HERE
Maintain high cell quality from research bench to clinical bedside.
Cell phenotype drift during scale-up is avoidable. G-Rex bioreactors, combined with high-quality reagents, maintain cell phenotype profiles across small and large scale expansion.
GMP raw materials for any process at any scale.
Raw material quality, supply, and process fit won’t be an issue. ScaleReady’s adaptable workflow, flexible filling, and supply agreements for GMP reagents ensure process customization and supply security as you scale.
Latest ScaleReady news and events.
ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies
Drug Discovery World: Looking ahead for cell and gene therapy
MaxCyte: MaxCyte Announces Collaboration with ScaleReady to Participate in the G-Rex Grant Program
Get in touch to begin scaling up and scaling out.
Let’s talk more about how ScaleReady can advance your cell and gene therapy research and manufacturing with ingenious efficiency.